Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 6/20 | 0.40 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.39 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.39 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.37 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.37 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2385767 | 0.85 | S1PR1 (0.51) | S1PR1S1PR3S1PR5 | |
| SCHEMBL18601658 | 0.85 | SIGMAR1 (0.41) | BCHEROCK1ROCK2KCNH2SIGMAR1 | |
| SCHEMBL15042521 | 0.85 | S1PR1 (0.39) | BCHESIGMAR1SLC2A1S1PR1S1PR3 | |
| SCHEMBL18601656 | 0.81 | SIGMAR1 (0.40) | BCHEROCK1ROCK2KCNH2SIGMAR1 | |
| SCHEMBL18601666 | 0.80 | SLC6A9 (0.39) | BCHEROCK1ROCK2KCNH2SIGMAR1 | |
| SCHEMBL18601662 | 0.78 | SIGMAR1 (0.40) | BCHESIGMAR1SLC2A1S1PR1S1PR3 | |
| SCHEMBL18601653 | 0.77 | HTR1A (0.45) | BCHESIGMAR1SLC2A1S1PR1S1PR3 | |
| SCHEMBL18601654 | 0.77 | HTR1A (0.45) | BCHESIGMAR1SLC2A1 | |
| SCHEMBL1977951 | 0.74 | S1PR5 (0.49) | S1PR1S1PR3S1PR5 | |
| SCHEMBL15042627 | 0.72 | BCHE (0.39) | BCHEROCK1SIGMAR1S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2504323-B1 | NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY | ALLERGAN INC (US) | 2017-03-15 | — | — | EP | claimed |